Photocure Asa patents expiration
1. Cysview Kit patents expiration
| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US6034267 | PHOTOCURE ASA | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
Mar, 2016
(8 years ago) | |
| US7247655 | PHOTOCURE ASA | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
Mar, 2016
(8 years ago) | |
| US7530461 | PHOTOCURE ASA | Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
Jan, 2017
(7 years ago) | |
| US7348361 | PHOTOCURE ASA | Solution for diagnosing or treating tissue pathologies |
Nov, 2020
(3 years ago) | |
| US11311620 | PHOTOCURE ASA | Neoadjuvant therapy for bladder cancer |
Dec, 2036
(12 years from now) | |
| US10556010 | PHOTOCURE ASA | Neoadjuvant therapy for bladder cancer |
Dec, 2036
(12 years from now) | |
| US11235168 | PHOTOCURE ASA | Method of photodynamic therapy (PDT) for bladder cancer |
Jan, 2038
(13 years from now) | |
| Drug Exclusivity | Drug Exclusivity Expiration |
|---|---|
| M(M-220) | Feb 15, 2021 |
| New Product(NP) | May 28, 2013 |
Drugs and Companies using HEXAMINOLEVULINATE HYDROCHLORIDE ingredient
Market Authorisation Date: 28 May, 2010
Treatment: Detection of non-muscle invasive papillary cancer of the bladder by photodynamic cystoscopy; Detection of carcinoma in the bladder by photodynamic cystoscopy
Dosage: FOR SOLUTION;INTRAVESICAL
More Information on Dosage
CYSVIEW KIT family patents
